Skip to main content
padlock icon - secure page this page is secure

Open Access Catheter Ablation of Atrial Fibrillation: Where Are We?

Download Article:
(HTML 149.7 kb)
(PDF 2,062.7 kb)
Atrial fibrillation (AF) is the commonest cardiac arrhythmia, with significant morbidity and mortality. More than half of patients with AF are still symptomatic despite adequate anticoagulation and rate control. If antiarrhythmic drugs are ineffective or poorly tolerated, AF patients are then typically treated with catheter ablation to restore sinus rhythm. In the past 20 years, AF ablation has developed from a specialized, experimental procedure into a common treatment in the cardiovascular field. Various ablation techniques and mapping technologies have been described and are continuing to evolve for increased safety and efficacy. An incomplete list of such techniques and technologies would include focal and segmental, circumferential and linear, complex fractionated atrial electrogram, ganglionated plexus, focal impulse and rotor modulation, body surface potential mapping‐guided, real-time MRI‐guided, cryoballoon, visually guided laser balloon, radiofrequency hot balloon, contact force sensing catheter, multielectrode catheter, and hybrid ablations. This review examines the history of invasive AF treatment and its evolution into catheter ablation but mainly focuses on the discussion of various ablation techniques and technologies leading to our current understanding of the ablation therapy of this most common arrhythmia.
No References for this article.
No Supplementary Data.
No Article Media
No Metrics

Keywords: Atrial fibrillation; Cardiac arrhythmia; Catheter ablation; Invasive cardiology

Document Type: Research Article

Publication date: February 1, 2017

This article was made available online on May 5, 2017 as a Fast Track article with title: "Catheter Ablation of Atrial Fibrillation: Where Are We?".

More about this publication?
  • Cardiovascular Innovations and Applications (CVIA) publishes focused articles and original clinical research that explore novel developments in cardiovascular disease, effective control and rehabilitation in cardiovascular disease, and promote cardiovascular innovations and applications for the betterment of public health globally. The journal publishes basic research that has clinical applicability in order to promote timely communication of the latest insights relating to coronary artery disease, heart failure, hypertension, cardiac arrhythmia, prevention of cardiovascular disease with a heavy emphasis on risk factor modification. Cardiovascular Innovations and Applications is the official journal of the Great Wall International Congress of Cardiology (GW-ICC). It aims to continue the work of the GW-ICC by providing a global scientific communication platform for cardiologists that bridges East and West.

  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Membership Information
  • Information for Advertisers
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more